en Ardeparin

Ardeparin
Clinical data
AHFS/Drugs.com	Multum Consumer Information
Routes of; administration	Injection
ATC code	None;
Legal status
Legal status	US: ℞-only;
Pharmacokinetic data
Bioavailability	92%
Identifiers
	IUPAC name 6-[5-acetylamino-4,6-dihydroxy-2-(sulfooxymethyl)tetrahydropyran-3-yl]oxy-3-[5-(6-;
CAS Number	9041-08-1 ;
DrugBank	DB00407 ;
ChemSpider	none;
UNII	N3927D01PB;
ChEMBL	ChEMBL1201448 ;
CompTox Dashboard (EPA)	DTXSID301010914 ;
ECHA InfoCard	100.110.590
Chemical and physical data
Formula	(C26H40N2O36S5)n
Molar mass	5500–6500 g/mol (average)
	(what is this?) (verify)

Ardeparin (brand name Normiflo) is an anticoagulant. It was used for the prevention of deep vein thrombosis, but was withdrawn from the US market in 2000 for reasons unrelated to safety or efficacy.^[1]^[2]^[3]

References

^ Frishman WH, Cheng-Lai A, Chen J (2000). "Antithrombotic therapy". Current cardiovascular drugs (3rd ed.). Philadelphia, Pa.: Current Medicine. p. 90. ISBN 978-1-4615-6767-7.
^ "Normiflo". Drugs.com. Archived from the original on 19 February 2017. Retrieved 23 January 2018.
^ "Determination That Ardeparin Sodium Injection Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness". United States Food and Drug Administration. Federal Register. 23 May 2002. Retrieved 24 June 2022.

This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.

[1] Frishman WH, Cheng-Lai A, Chen J (2000). "Antithrombotic therapy". Current cardiovascular drugs (3rd ed.). Philadelphia, Pa.: Current Medicine. p. 90. ISBN 978-1-4615-6767-7.

[2] "Normiflo". Drugs.com. Archived from the original on 19 February 2017. Retrieved 23 January 2018.

[3] "Determination That Ardeparin Sodium Injection Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness". United States Food and Drug Administration. Federal Register. 23 May 2002. Retrieved 24 June 2022.

[1]

[2]

[3]